2016 Bonus and Supplemental Bonus Awards for Executive Officers of NewLink Genetics Corporation
Contract Categories:
Human Resources
›
Bonus & Incentive Agreements
Summary
This document outlines the 2016 bonus and supplemental bonus awards for key executives of NewLink Genetics Corporation, including the Chairman, President, CFO, Vice President of Finance, and Chief Commercial Officer. It specifies each executive's annual salary, target bonus, actual bonus awarded (at 50% of the target), and any supplemental bonus amounts. The agreement details the compensation structure for these executives for the 2016 fiscal year.
EX-10.1 2 nlnk-20170105x8kxex101.htm EXHIBIT 10.1 Exhibit
Exhibit 10.1
2016 Bonus Awards and Supplemental Bonus Awards | |||||
Name and Title | 2016 Annual Salary | Goal Bonus at 100% | Bonus Awarded | Bonus Amount | Supplemental Bonus Amount |
Charles J. Link, Jr., M.D. | $659,900 | $461,930 | 50% | $230,965 | $55,000 |
Chairman of the Board and Chief Executive and Scientific Officer | |||||
Nicholas N. Vahanian, M.D. | $574,300 | $287,150 | 50% | $143,575 | $43,000 |
Director, President and Chief Medical Officer | |||||
John B. Henneman, III | $423,600 | $169,440 | 50% | $84,720 | $26,250 |
Chief Financial Officer | |||||
Carl Langren | $277,500 | $83,250 | 50% | $41,625 | $12,625 |
Vice President of Finance | |||||
Brian Wiley | $370,700 | $129,745 | 50% | $64,873 | $19,525 |
Chief Commercial Officer | |||||
